RMC No. 129-2022: Publishes the September 1, 2022 letter from the Food and Drug Administration of the DOH endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act)

Files
Download this file

Summary

RMC No. 129-2022 publishes the September 1, 2022 letter of the Food and Drug Administration (FDA) endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act).

CollapseExpand

Key points

  1. Update to the list. The update deletes certain medicines prescribed for mental illnesses from the List of VAT-Exempt Medicines.
  2. Source of the letter. The letter comes from FDA Director General Samuel A. Zacate.

Deadlines and effectivity

  • Letter dated September 1, 2022

Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.

Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.